DeutschNewstral
Article
bizjournals.com on 2022-05-25 17:45
Noveome Biotherapeutics earns FDA designations for new biologic application
Related news
FDA Issues Guidance Regarding Biologic Drug Namingjdsupra.com- Iovance Biotherapeutics CEO resigns as FDA raises manufacturing questionsbizjournals.com
- Biogen scores FDA approval for generic eye disease biologicbizjournals.com
- FDA Issues Guidance Regarding Interchangeability of Biosimilar and Biologic Drugsjdsupra.com
GlycoMimetics gets patent, FDA designations for cancer drugthedailyrecord.com- Harmony's lead new drug candidate receives 2 FDA designationsbizjournals.com
- Is it a drug, device, biologic, or combination product? FDA issues final guidance on classificationjdsupra.com
- FDA updates industry on what drug & biologic inspections will occur during COVID-19 pandemicjdsupra.com
- FDA Issues Guidance on Drug and Biologic Submissions with Real-World Data and Real-World Evidencejdsupra.com
- FTC and FDA Announce Plans to Combat Anticompetitive Practices in the "Biologic Marketplace"jdsupra.com
- FDA Classifies Insulin as Biologic; Biosimilar Insulin Applications Accepted Beginning March 23, 2020jdsupra.com
- FDA Approves Breyanzi®—A New Biologic for Treating Large B-Cell Lymphomajdsupra.com
- Artiva Biotherapeutics Receives FDA Fast Track Designation for AlloNK in Lupus Nephritisjdsupra.com
- Mylan submits new drug application to FDAbizjournals.com
- FDA Adjustment to Orphan Drug Review May Indicate Increased Scrutiny of Designationsjdsupra.com
- FDA accepts Coherus’s resubmitted pegfilgrastim biosimilar applicationjdsupra.com
- Shares climb for Norwood firm working on cystic fibrosis drug after FDA designationsbizjournals.com
- FDA grants two key designations to Passage Bio's experimental Krabbe disease therapybizjournals.com
- MediBeacon device earns ‘breakthrough’ designation from FDAbizjournals.com
Breakthrough Alzheimer's drug earns accelerated FDA approvalNew York Post